{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:10:47Z","timestamp":1790115047368,"version":"4.0.1"},"reference-count":27,"publisher":"AMPCo","issue":"9","license":[{"start":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T00:00:00Z","timestamp":1526256000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Australian Department of Health"},{"name":"Aged Care Services Improvement and Healthy Ageing Grants","award":["3-6D8KE"],"award-info":[{"award-number":["3-6D8KE"]}]},{"name":"National Health and Medical Research Council Translating Research Into Practice"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Journal of Australia"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.5694\/mja17.00857","type":"journal-article","created":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T06:38:51Z","timestamp":1526020731000},"page":"398-403","source":"Crossref","is-referenced-by-count":96,"title":["RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities"],"prefix":"10.5694","volume":"208","author":[{"given":"Juanita L","family":"Westbury","sequence":"first","affiliation":[{"name":"Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gee","sequence":"additional","affiliation":[{"name":"University of Tasmania, Hobart, TAS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Ling","sequence":"additional","affiliation":[{"name":"University of Tasmania, Hobart, TAS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donnamay T","family":"Brown","sequence":"additional","affiliation":[{"name":"Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine H","family":"Franks","sequence":"additional","affiliation":[{"name":"Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Bindoff","sequence":"additional","affiliation":[{"name":"University of Tasmania, Hobart, TAS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan","family":"Bindoff","sequence":"additional","affiliation":[{"name":"Wicking Dementia Research and Education Centre, University of Tasmania, Hobart, TAS"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M","family":"Peterson","sequence":"additional","affiliation":[{"name":"University of Tasmania, Hobart, TAS"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3677","published-online":{"date-parts":[[2018,5,14]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.3109\/00048670903489890"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270011405665"},{"key":"e_1_2_8_4_1","unstructured":"Royal Australian and New Zealand College of Psychiatrists.Antipsychotic medications as a treatment of behavioural and psychological symptoms of dementia (Professional Practice Guideline 10). Aug2016.https:\/\/www.ranzcp.org\/Files\/Resources\/College_Statements\/Practice_Guidelines\/pg10\u2010pdf.aspx(viewed Apr 2017)."},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160126"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2014.3018"},{"key":"e_1_2_8_7_1","volume-title":"Benzodiazepines. 3.4. Older patients. In: Prescribing drugs of dependence in general practice, Part B","author":"Royal Australian College of General Practitioners","year":"2015"},{"key":"e_1_2_8_8_1","unstructured":"BanerjeeS.The use of antipsychotic medication for people with dementia: time for action.Department of Health (UK) 2009.https:\/\/www.rcpsych.ac.uk\/pdf\/Antipsychotic%20Bannerjee%20Report.pdf(viewed Mar 2017)."},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610211000445"},{"key":"e_1_2_8_10_1","unstructured":"Center for Clinical Standards and Quality\/Survey and Certification Group (Centers for Medicare & Medicaid Services US Department of Health and Human Services).Update report on the National Partnership to Improve Dementia Care in Nursing Homes (S&C: 16\u201328\u2010NH) [memorandum]. June2016.https:\/\/www.cms.gov\/Medicare\/Provider\u2010Enrollment\u2010and\u2010Certification\/SurveyCertificationGenInfo\/Downloads\/Survey\u2010and\u2010Cert\u2010Letter\u201016\u201028.pdf(viewed Mar 2017)."},{"key":"e_1_2_8_11_1","unstructured":"The Senate Community Affairs References Committee.Care and management of younger and older Australians living with dementia and behavioural and psychiatric symptoms of dementia (BPSD). Mar2014.http:\/\/www.aph.gov.au\/Parliamentary_Business\/Committees\/Senate\/Community_Affairs\/Dementia\/Report\/index(viewed Mar 2017)."},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/13607863.2015.1063102"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610209991128"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1017\/S104161021600082X"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-7-38"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1741-6787.2010.00202.x"},{"key":"e_1_2_8_17_1","unstructured":"Australian Government Department of Health.Australian Statistical Geographical Standard Remoteness Areas (2011) locator.DoctorConnect[website].http:\/\/www.doctorconnect.gov.au\/internet\/otd\/publishing.nsf\/Content\/ASGSRA_locator(viewed Apr 2017)."},{"key":"e_1_2_8_18_1","unstructured":"Australian Institute of Health and Welfare.Residential aged care and home care 2014\u201315: supporting data.https:\/\/www.gen\u2010agedcaredata.gov.au\/Resources\/Access\u2010data\/2015\/December\/Residential\u2010aged\u2010care\u2010and\u2010Home\u2010Care\u20102014%E2%80%9315\u2010suppo(viewed Mar 2017)."},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6938"},{"key":"e_1_2_8_20_1","unstructured":"World Health Organization Collaborating Centre for Drug Statistics Methodology.ATC\/DDD index: N. Nervous system.https:\/\/www.whocc.no\/atc_ddd_index\/?code=N(viewed Mar 2017)."},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0607"},{"key":"e_1_2_8_22_1","unstructured":"Drug and Alcohol Services South Australia.Benzodiazepines: information for GPs. Aug2014.http:\/\/www.sahealth.sa.gov.au\/wps\/wcm\/connect\/dbd6d500407749f193d6bb222b2948cf\/Benzodiazepines+\u2010+GPs+2017.pdf?MOD=AJPERES&CACHEID=dbd6d500407749f193d6bb222b2948cf&CACHE=NONE(viewed Mar 2017)."},{"key":"e_1_2_8_23_1","volume-title":"Reducing the Use of Sedative medication in aged care facilities: implementation of the RedUSe' project into everyday practice","author":"Westbury J","year":"2016"},{"key":"e_1_2_8_24_1","doi-asserted-by":"crossref","first-page":"e009882","DOI":"10.1136\/bmjopen-2015-009882","article-title":"Antipsychotic prescribing in care homes before and after launch of a national dementia strategy: an observational study in English institutions over a 4\u2010year period","volume":"6","author":"Szczepura A","year":"2016","journal-title":"BMJ Open"},{"key":"e_1_2_8_25_1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/bcp.12847","article-title":"Effects of a geriatric intervention aiming to improve quality care in nursing homes on benzodiazepine use and discontinuation","volume":"81","author":"Souto Barreto P","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_2_8_26_1","unstructured":"YangY ChenT BeazleyB et al.An audit of psychotropic medication monitoring in Australian aged care facilities [abstract].Australasian Pharmaceutical Society of Australia Brisbane 5\u20137 December 2014; paper 132.http:\/\/apsa\u2010online.org\/files\/2014ConferenceProceedings.pdf(viewed Mar 2017)."},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-10-321"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610211000421"}],"container-title":["Medical Journal of Australia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.5694%2Fmja17.00857","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.5694\/mja17.00857","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.5694\/mja17.00857","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.5694\/mja17.00857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T03:11:32Z","timestamp":1626923492000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.5694\/mja17.00857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,4,9]]},"published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.5694\/mja17.00857"],"URL":"https:\/\/doi.org\/10.5694\/mja17.00857","archive":["Portico"],"relation":{},"ISSN":["0025-729X","1326-5377"],"issn-type":[{"value":"0025-729X","type":"print"},{"value":"1326-5377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}